Author Correction: Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors (Scientific Reports, (2023), 13, 1, (5349), 10.1038/s41598-023-32321-0)

Correction to: Scientific Reports, published online 01 April 2023 The original version of this Article contained an error in Figure 3, panel g, where the phospho STAT5 band was incorrectly located in the second lane. The original Figure 3 and accompanying legend appear below. (Figure presented.) NF-κB is activated in tumor-conditioned macrophages treated with JAK inhibitors. (a–d) Immunoblot and quantification of protein lysates from BMDMs treated with CM from HC11/R1 cells (a,b) and 4T1 cells with ruxolitinib (c,d). (e–h) immunoblot of BMDMs treated with CM from 4T1 cells with solcitinib (e,f) and NVP-BSK805 (g,h). *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001 Representative blots from n = 3 biological replicates. The original Article has been corrected.